Innovative heart monitoring solutions AccurKardia AccurECG recognized as the top "New Technology Solution for ECG" in the industry
In the rapidly evolving digital healthcare industry, this year's MedTech Breakthrough Awards highlighted the groundbreaking work of various companies and startups across the globe. One of the recipients of this prestigious recognition is AccurKardia, for its innovative AccurECG software platform.
AccurECG provides automated, near real-time beat-by-beat ECG analysis across multiple arrhythmias. This technology integrates with diverse hardware, including short duration recordings from ECG systems and multi-day Holter or patch monitors, making it versatile and adaptable to a wide range of medical settings.
Beyond AccurECG, AccurKardia has recently collaborated with HeartBeam to integrate its AI-powered AccurECG algorithm into HeartBeam’s innovative cable-free, credit card-sized ECG device. This partnership aims to enhance diagnostic capabilities for arrhythmia and ischemia detection outside traditional healthcare settings, expanding remote cardiac care access. HeartBeam is preparing for a pilot commercial launch in 2025 and a full launch in 2026, with ongoing FDA discussions for 12-lead synthesis software clearance and ischemia indications.
AccurKardia's AccurECG was not the only innovation recognised by the awards. The company also received FDA Breakthrough Device Designations for two novel applications in 2024: AK-AVS and AK+ Guard. AK-AVS is an ECG-based AI algorithm that screens for and enables early detection of moderate to severe Aortic Valve Stenosis. AK+ Guard, on the other hand, is a Lead I ECG-based, AI-powered hyperkalemia detection tool designed for consumer and clinical wearables.
The MedTech Breakthrough Awards program honours excellence and innovation in the health and medical technology industry. This year, the program received a record-breaking number of nominations from leading companies and startups across over 18 countries, reflecting the global impact and momentum of the digital healthcare industry. MedTech Breakthrough is an independent market intelligence organisation that aims to recognise the top companies, products, and services in the rapidly evolving health and medical technology market.
AccurKardia's win is a testament to the company's commitment to driving meaningful progress and improving patient care through innovative solutions. The digital health and AI insights section frequently covers such innovations and advancements in the healthcare technology industry, providing in-depth analysis and trends shaping the future of healthcare technology.
As the digital healthcare industry continues to grow and evolve, it's clear that companies like AccurKardia will play a significant role in shaping the future of healthcare, with their focus on developing AI-powered solutions that enhance diagnostic capabilities and expand access to remote cardiac care.
- The digital health industry, as demonstrated by the MedTech Breakthrough Awards, recognizes and celebrates companies like AccurKardia that are driving meaningful progress through innovative solutions, such as their AccurECG software.
- AccurKardia's partnership with HeartBeam, incorporating the AccurECG algorithm into HeartBeam's innovative medical device, aims to increase diagnostic capabilities for arrhythmia and ischemia detection beyond traditional healthcare settings, promoting health-and-wellness in remote areas.
- In the health-and-wellness sector, technology advances in medical devices, like AK-AVS and AK+ Guard by AccurKardia, are transforming patient care with AI-powered solutions, enabling early detection of medical-conditions like moderate to severe Aortic Valve Stenosis and hyperkalemia, respectively.
